|
|
Advice for patients on painkiller/anti-inflammatory - Celebrex.
- Article from:
-
M2 Presswire
- Article date:
-
December 21, 2004
|
Copyright informationCOPYRIGHT 2004 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-21 December 2004-UK Government: Advice for patients on painkiller/anti-inflammatory - Celebrex(C)1994-2004 M2 COMMUNICATIONS LTD
RDATE:12212004
The Medicines and Healthcare products Regulatory Agency (MHRA) today issued new advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex.
Patients who are taking Celebrex, Bextra and Arcoxia should make a non-urgent appointment with their GP to review their treatment.
Patients who have established heart disease or who are at high risk of stroke will have their treatment changed. For all other patients, alternative treatments will be considered on the basis of their medical history.